ArticleiScience2026
A dual granular balanced deep forest model for effective drug combination prediction.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment of complex diseases often benefits from combination therapies, yet identifying synergistic drug pairs remains challenging due to the vast search space and the extreme imbalance between synergistic and non-synergistic outcomes in available data. Here, we present a deep-forest-based framework designed to improve synergy prediction under highly skewed class distributions by prioritizing informative and uncertain training examples during learning. Experiments demonstrate that our method consistently achieves favorable results relative to a broad set of representative canonical, imbalanced learning, and drug-specific prediction models. Beyond predictive accuracy, we provide model interpretability analyses to highlight chemical substructures and cell-line-specific genetic signals associated with synergy, and we further validate top-ranked predictions through literature- and database-supported case studies. Together, these results suggest a practical and interpretable approach for accelerating the discovery of biologically plausible synergistic drug combinations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.